A phase 1B, open-label, dose-escalation study of bortezomib in combination with gemcitabine (Gem) and cisplatin (Cis) in the first-line treatment of patients with advanced solid tumors: Preliminary results of a phase IB study.

J Voortman, EF Smit, BC Kuenen, HM Pinedo, C van Groeningen, AJ van den Eertwegh, D Brouwer, H van de Velde, G Giaccone

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
Pages (from-to)160S-160S
JournalJournal of Clinical Oncology
Volume23
Issue number16
Publication statusPublished - 1 Jun 2005

Cite this